CN101347530A - Oral liquid for regulating blood fat and blood sugar - Google Patents
Oral liquid for regulating blood fat and blood sugar Download PDFInfo
- Publication number
- CN101347530A CN101347530A CNA2008101962499A CN200810196249A CN101347530A CN 101347530 A CN101347530 A CN 101347530A CN A2008101962499 A CNA2008101962499 A CN A2008101962499A CN 200810196249 A CN200810196249 A CN 200810196249A CN 101347530 A CN101347530 A CN 101347530A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- blood
- extract
- fructus crataegi
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 42
- 210000004369 blood Anatomy 0.000 title claims abstract description 37
- 239000008280 blood Substances 0.000 title claims abstract description 37
- 235000000346 sugar Nutrition 0.000 title abstract description 11
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- 239000011651 chromium Substances 0.000 claims abstract description 23
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 21
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000008103 glucose Substances 0.000 claims abstract description 11
- 239000008213 purified water Substances 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims description 18
- 230000033228 biological regulation Effects 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 239000000469 ethanolic extract Substances 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 3
- 241000699670 Mus sp. Species 0.000 abstract description 3
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 2
- 206010036067 polydipsia Diseases 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 2
- 235000020717 hawthorn extract Nutrition 0.000 abstract 2
- 208000006083 Hypokinesia Diseases 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 230000003907 kidney function Effects 0.000 abstract 1
- 230000003908 liver function Effects 0.000 abstract 1
- 231100000989 no adverse effect Toxicity 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000006870 function Effects 0.000 description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 5
- 235000011613 Pinus brutia Nutrition 0.000 description 5
- 241000018646 Pinus brutia Species 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000003672 processing method Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 241000628997 Flos Species 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 239000006286 aqueous extract Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 235000003935 Hippophae Nutrition 0.000 description 1
- 241000229143 Hippophae Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241001523405 Limax Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an oral liquid for regulating blood-fat and blood sugar; the oral liquid is prepared by cassia seed extract and hawthorn extract which are extracted by alcohol extracting and water precipitating and chromium yeast with purified water; each liter of the oral liquid contains 0.4-0.6kg of cassia seed extract, 0.3-0.4kg of hawthorn extract, and 8-15g of chromium yeast. Proved by animal experiments, the oral liquid can regulate the blood-fat and blood sugar of test rats and test mice; the clinical feeding trials show that the fasting blood-glucose of type II diabetic patients reduces by average 2.32mmol/L after a patient takes the oral liquid for one month, and the total effective rate reaches over 90%; furthermore, the oral liquid can alleviate the main clinical symptoms such as polydipsia, pleophagy, polyuria, hypodynamia, and the like, and has no adverse effect on the liver function and the renal function of patients.
Description
One, technical field
The present invention relates to a kind of health food, particularly a kind of health care oral liquid, specifically a kind of oral liquid with blood lipid regulation and blood sugar regulation effect.
Two, background technology
Along with improving constantly of The development in society and economy and people's living standard, higher fatty acid, the diet of high heat and busy work make the sickness rate of China's hyperglycemia, hyperlipidemia more and more high.China's blood sugar regulation, blood lipid regulation are at present mainly with compositions such as spirulina, Fructus Crataegi, Semen Cassiae, Flos Carthami, Fructus Hippophae, Radix Glycyrrhizaes, adopt different processing methods to make tablet or capsule, the energy blood fat reducing, reduce serum total cholesterol, remove the blood vessel wall cholesterol, alleviate atherosclerosis, suppress lipid peroxidation, improve immunity of organism and regulate the nutritive equilibrium state; Or adopt single modernized biological product-chromium yeast auxotype additive.
The sky that Wuhan City's gold Hypon biological product company limited is developed flies a board gold Hypon oral liquid, is that primary raw material is made by Radix et Rhizoma Rhei (processed), Fructus Crataegi, Folium Nelumbinis, Fructus Lycii, Semen Cassiae, Radix Polygoni Multiflori Preparata, and suitable crowd is the higher person of blood fat.The Caulis Entadae board sky arteries and veins oral liquid of Guangdong Yuelong Pharmaceutical Co., Ltd and the limited public responsible company of Zhengzhou Milky Way Pharmaceutical Development and Production, by Fructus Crataegi, Fructus Hordei Germinatus, Fructus Momordicae charantiae, xylitol, purified water is that primary raw material is made, and suitable crowd is the higher person of blood fat, the higher person of blood glucose.The honor arteries and veins fat board gynostemium pentaphylla oral liquid that Jiangxi Prov. Medicine Inst and Jiangxi Ning Gang natural health-care beverage factory develop is that primary raw material is made by Herb Gynostemmae Pentaphylli, Folium Nelumbinis, Semen Cassiae, Fructus Crataegi, Fructus Lycii, Flos Chrysanthemi, cyclamate, the suitable higher person of crowd's blood fat.The easypro thirsty oral liquid of the Onlly of Only Co., Ltd., Shanghai Jiantong Univ.'s development, primary raw material is medicine-food two-purpose Chinese herbal medicine such as Radix Glehniae, Fructus Crataegi, Rhizoma Dioscoreae, Rhizoma Phragmitis, product has the health-care effect of blood sugar regulation.
The disclosed Maikary oral liquor of CN1515280A is made up of following main materials: Limax 10-100 weight portion, snail ovum 10-100 weight portion, rice vinegar 500-2000 weight portion.Can also be added with Semen Cassiae 20-200 weight portion in the described primary raw material, Fructus Lycii 10-100 weight portion, Flos Chrysanthemi 20-200 weight portion, Fructus Crataegi 10-100 weight portion.Advantage of the present invention: scalable blood fat, blood pressure regulation, recovery health, be a kind of good nutriment, without any side effects.
CN1325088C discloses a kind of oral administration liquor for reducing blood fat that is used for the treatment of hyperlipemia, form by Fructus Crataegi cuneatae 30 grams, Radix Puerariae 15 grams, Semen Cassiae 15 grams, Rhizoma Alismatis 15 grams, Folium Ginkgo 10 grams, Fructus Crataegi cuneatae, Radix Puerariae, Semen Cassiae, Rhizoma Alismatis, Folium Ginkgo are ground the end jointly, put into extraction pot and add 10 kilograms of filtrations of height Chinese liquor, adding crystal sugar dissolves, not stopping stirs is oral administration liquor for reducing blood fat, has blood fat reducing, antiatherogenic function, with after have no side effect, the clinic trial effective percentage reaches more than 90%, makes hypertension drop to normal value in the short time.
CN1096686A discloses a kind of efficient phospholipid nutrient oral liquor, it is to be major ingredient with the soybean phospholipid, add that VE and unsaturated fatty acid mix, adjuvant is Fructus Crataegi, Semen Cassiae, add water boil, leach slag and stay juice, adjuvant juice and major ingredient mix, and add essence, promptly get product through dispersion, filtration, homogenizing, packing, sterilization, check again.This product can make the middle-older patient blood fat reducing, reduces blood viscosity, and the prevention of arterial sclerosis reaches the danger of prophylactic treatment cardiovascular disease and releasing cerebral thrombosis.
" Jilin agricultural rural economy information " 2005 (8)-19 discloses a kind of chromium yeast auxotype additive, can be applicable to the medicines and health protection field, to the effective blood sugar lowering of diabetics; Also can be applicable to field of fodder, can increase the lean meat ratio of domestic animal, improve milk yield of cattle and sheep and the egg production of domestic animal.This Harbin City's brainstorm project " bioanalysis prepares the pilot scale research of rare earth organic chromium feed addictive " by " Harbin Institute of Technology " development is identified by province Science and Technology Department.Expert group is thought, adopts the method for adding LREE in the culture medium to promote the formation of organic chromium, has obtained breakthrough achievement.
Three, summary of the invention
The present invention is intended to provide for the public oral liquid of a kind of scalable blood fat and blood glucose, and technical problem to be solved is an optimization formula, not only scalable blood fat but also scalable blood glucose.
Technical scheme of the present invention is to extract Semen Cassiae with the oral liquid that active component in the Fructus Crataegi (calling extract in the following text) and chromium yeast dispose with purified water with ethanol extract from water precipitation, contains 0.4-0.6kg Semen Cassiae extract, 0.3-0.4kg Fructus Crataegi extract and 8-15g chromium yeast in every liter of oral liquid.
Contain 0.40-0.52kg Semen Cassiae extract, 0.30-0.36kg Fructus Crataegi extract and 8.0-12g chromium yeast in preferred every liter of oral liquid.
Further contain 0.46kg Semen Cassiae extract, 0.33kg Fructus Crataegi extract and 10g chromium yeast in preferred every liter of oral liquid.
Ethanol extract from water precipitation is to extract one of Chinese herbal medicine active component traditional method.Be exactly at first Semen Cassiae and Fructus Crataegi to be carried out reflux, extract, in this application with 80%-85% ethanol, obtain ethanol extract, slough ethanol then and obtain concentrated solution, add 3 times of water in concentrated solution, air agitation 30 minutes cools to 12-15 ℃, static placement is after 18-30 hour, separate with centrifuge, remove floating thing and precipitate and obtain clear liquid (aqueous extract) after the processing of Semen Cassiae and Fructus Crataegi, this aqueous extract is used for preparing oral liquid.
This oral liquid detects through the disease prevention and control center, Anhui Province, the result following (examining report numbering: 07BSW0426L):
Test item unit's testing result operative norm
[1] pH value-4.62 4.2～5.8
[2] plumbous (in Pb) mg/L＜0.25≤0.5
[3] arsenic (in As) mg/L 0.042≤0.3
[4] organic chromium is (with Cr
3+) μ g/100ml 183.2 〉=160 ± 25%
[5] total chromium (in Cr) mg/L 1.834≤2.0
[6] total solid % 13.3 〉=3
[7] total flavones mg/100mL 500 〉=112.
This oral liquid carries out blood lipid regulation effect food function by Nanjing railway hospital analyzing and testing center by " the health food function assessment is estimated and the method for inspection " and learns detection.Examining report (report number: conclusion (food) searching 990036-2 number) is:
1, the experimental rat body weight there is not influence.
2, experimental rat serum total cholesterol (TCHO) there is not influence.
3, when 5ml/kg.BW (be equivalent to human body recommended intake 5 times) and above dosage, has the effect that reduces experimental rat serum triglycerides (TG).
4, when 10ml/kg.BW (quite 10 times of the human body recommended intake) and above dosage, has the effect of increasing experimental rat serum high-density LP cholesterol (HDL-C).
In a word, this oral liquid has the effect of blood lipid regulation when 5ml/kg.BW.
This oral liquid carries out blood sugar regulation effect food function by Nanjing Medical University's nutrition and Food Science technical research institute by " the health food function assessment is estimated and method of inspection " and learns detection.Examining report (report number: 0990041) conclusion is:
This oral liquid gives back mensuration fasting glucose with 5ml/kg.BW, 10ml/kg.BW and three other dosage of level of 30ml/kg.BW to normal mouse and hyperglycemia model mice filling in continuous 30 days stomach, and the result shows that normal mouse fasting glucose and carbohydrate tolerance are not had influence; To the mice diabetic model group that alloxan is made, three kinds of dosage all have the effect that reduces the mice fasting glucose and improve the carbohydrate tolerance level.Show that this oral liquid has the effect of blood sugar regulation.
This oral liquid carries out clinical blood sugar regulation human feeding trial by Nanjing Medical University's nutrition and Food Science technical research institute and Nanjing Medicine University subsidiary Nanjing first hospital by " the health food function assessment is estimated and the method for inspection ". result of the test:
1, after 30 routine type ii diabetes patients take one month, the fasting glucose 2.32mmol/L that on average descends, wherein produce effects 5 examples account for 16.7%, and effective 22 examples account for 73.3%, total effective rate 90.0%, and the blood glucose after two hours after the meal also obviously reduces.
2, the polydipsia that type ii diabetes is suffered from, polyphagia, polyuria, main clinic symptoms such as weak have some improvement.
3, do not see untoward reaction during the test-meal, and erythrocyte, leukocyte, hemoglobin, total serum protein, albumin, glutamate pyruvate transaminase, creatinine, blood urea nitrogen etc. show that all in normal range liver, the stomach function to the people has no adverse effects before and after the test-meal.
Conclusion is that this oral liquid has the blood sugar regulation effect to the type ii diabetes patient,
Four, the specific embodiment
Be example to process 100 liters of oral liquids now, non-limiting examples is described below:
1, depends on that pine torch 40kg rejects foreign body, clean silt, dry naturally, get Fructus Crataegi 30kg, reject foreign body.Semen Cassiae and Fructus Crataegi are dropped in the reflux, extract, jar, add the 80%-85% alcoholic solution, medical material is immersed in the alcoholic solution and gets final product.Soaked 2-3 hour earlier, temperature rising reflux extracted 2-3 hour again, reflux finish after, refrigerated separation, medicinal residues reuse 83%-85% alcoholic solution reflux, extract, at least once, merging filtrate obtains ethanol extract.The ethanol extract vacuum is sloughed ethanol, obtains concentrated solution,
Add the water of about 3 times of volumes in concentrated solution, air agitation 30 minutes cools to 13 ℃, leave standstill 18-30 hour after, isolated by filtration obtains the primary water extracting solution.
Aqueous extract is diluted to 100 liters with purified water, adds the 0.8kg chromium yeast simultaneously and stir and just obtain oral liquid.
2, depend on pine torch 60kg, Fructus Crataegi 40kg, chromium yeast 1.5kg, process 100 liters of oral liquids, processing method use-case 1.
3, depend on pine torch 40kg, Fructus Crataegi 36kg, chromium yeast 1.2kg, process 100 liters of oral liquids, processing method use-case 1.
4, depend on pine torch 52kg, Fructus Crataegi 30kg, chromium yeast 1kg, process 100 liters of oral liquids, processing method use-case 1.
5, depend on pine torch 46kg, Fructus Crataegi 33kg, chromium yeast 1kg, process 100 liters of oral liquids, processing method use-case 1.
Claims (3)
1, a kind of blood lipid regulation, blood glucose oral liquid, be to extract the Semen Cassiae obtain and the extract in the Fructus Crataegi and chromium yeast with the oral liquid that purified water disposes, it is characterized in that: contain 0.4-0.6kg Semen Cassiae extract, 0.3-0.4kg Fructus Crataegi extract and 8-15g chromium yeast in every liter of oral liquid by ethanol extract from water precipitation.
2, oral liquid according to claim 1 is characterized in that: contain 0.40-0.52kg Semen Cassiae extract, 0.30-0.36kg Fructus Crataegi extract and 8-12g chromium yeast in every liter of oral liquid.
3, according to claim 1 or 2 described oral liquids, it is characterized in that: contain 0.46kg Semen Cassiae extract, 0.33kg Fructus Crataegi extract and 10g chromium yeast in every liter of oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101962499A CN101347530B (en) | 2008-08-26 | 2008-08-26 | Oral liquid for regulating blood fat and blood sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101962499A CN101347530B (en) | 2008-08-26 | 2008-08-26 | Oral liquid for regulating blood fat and blood sugar |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101347530A true CN101347530A (en) | 2009-01-21 |
| CN101347530B CN101347530B (en) | 2011-09-14 |
Family
ID=40266611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101962499A Active CN101347530B (en) | 2008-08-26 | 2008-08-26 | Oral liquid for regulating blood fat and blood sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101347530B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102119772A (en) * | 2011-01-26 | 2011-07-13 | 深圳市多微生保健食品有限公司 | Health oral liquid and preparation method thereof |
| CN108452229A (en) * | 2018-03-02 | 2018-08-28 | 宋彦霖 | Assist blood fat reducing preparation |
| CN109329689A (en) * | 2018-11-12 | 2019-02-15 | 天津市农业生物技术研究中心 | A kind of health solid beverage and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1070343A (en) * | 1992-09-05 | 1993-03-31 | 刚丕寰 | The preparation method of beverage with fat-reducing function |
| CN1054053C (en) * | 1995-03-11 | 2000-07-05 | 朱立群 | Medicine for reducing blood sugar and its preparation method and use |
-
2008
- 2008-08-26 CN CN2008101962499A patent/CN101347530B/en active Active
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102119772A (en) * | 2011-01-26 | 2011-07-13 | 深圳市多微生保健食品有限公司 | Health oral liquid and preparation method thereof |
| CN102119772B (en) * | 2011-01-26 | 2015-04-08 | 深圳市多微生保健食品有限公司 | Health oral liquid and preparation method thereof |
| CN108452229A (en) * | 2018-03-02 | 2018-08-28 | 宋彦霖 | Assist blood fat reducing preparation |
| CN109329689A (en) * | 2018-11-12 | 2019-02-15 | 天津市农业生物技术研究中心 | A kind of health solid beverage and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101347530B (en) | 2011-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102100805B (en) | Composition for relieving physical fatigue and enhancing immunologic function, preparation method thereof and application thereof | |
| CN1259935C (en) | Medicine for treating hyperlipemia | |
| CN102634441B (en) | A kind of preparation method of health-care vinegar | |
| CN106923337A (en) | A kind of preparation method and applications of spirulina full agonist | |
| CN101696444A (en) | Polypeptide extract as well as preparation method and application thereof | |
| CN105030984B (en) | A kind of semen litchi health care oral liquid and preparation method with hypoglycemic, tune rouge and alleviation diabetic complication | |
| CN105998093A (en) | Blood-glucose-lowering ganoderma lucidum instant micro-encapsulated preparation and preparation method thereof | |
| CN101347530B (en) | Oral liquid for regulating blood fat and blood sugar | |
| CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
| CN1558768A (en) | A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof | |
| CN105852063A (en) | Sargassum fusiforme polysaccharide-rich nutrition and health care product | |
| CN101244084B (en) | Sobering-up agent of pearl oyster and preparation thereof | |
| CN100363046C (en) | Prepn for treating fatty liver and alcoholic liver and its prepn process | |
| CN103977390B (en) | A kind of preparation method and its usage of ginger onion medicated wine composition | |
| CN102631466A (en) | Health care product for regulating blood lipid and preparation method thereof | |
| CN102335347B (en) | Panax pseudo-ginseng and panax quinquefolium soft capsules | |
| CN105106300A (en) | Use of cyclocarya paliurus extract in preparation of drug for preventing and treating non-alcoholic fatty liver disease | |
| CN101810649A (en) | Method for preparing pine needle distilled and concentrated solution | |
| CN100488546C (en) | Medicine for reducing blood sugar, blood pressure and improving microcirculation and immunity, and its preparation method | |
| CN108450941A (en) | A kind of dietary composition adjusting lipid metaboli | |
| CN1857599A (en) | Medicine for lowering blood sugar, blood fat and blood pressure, raising blood flow rate and raising immunity and its preparing method | |
| CN109316565B (en) | Blood fat reducing composition and preparation method and application thereof | |
| CN106265717A (en) | Dicliptera chinensis polysaccharide application in preparation preventing and treating diabetes medicament or health product | |
| CN1259851C (en) | sunflower extract product | |
| CN100394930C (en) | Application of cassia seed in preparation of lead-remove promoting drug or health-caring product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ANHUI PROVINCE HUAXIN BIOLOGY PHARMACY CO., LTD. Free format text: FORMER OWNER: ZHU HUIQIU Effective date: 20100115 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20100115 Address after: Anhui Province Jieshou City Zhongyuan Road No. 439 post encoding: 236500 Applicant after: Anhui Huaxin Natural Medicine Co., Ltd. Address before: Anhui Province Jieshou City Zhongyuan Road No. 439 post encoding: 236500 Applicant before: Zhu Huiqiu |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Oral liquid for regulating blood fat and blood sugar Effective date of registration: 20150911 Granted publication date: 20110914 Pledgee: The development of small and medium-sized enterprises financing Company Limited by Guarantee Jieshou City Pledgor: Anhui Huaxin Natural Medicine Co., Ltd. Registration number: 2015990000772 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20161020 Granted publication date: 20110914 Pledgee: The development of small and medium-sized enterprises financing Company Limited by Guarantee Jieshou City Pledgor: Anhui Huaxin Natural Medicine Co., Ltd. Registration number: 2015990000772 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Oral liquid for regulating blood fat and blood sugar Effective date of registration: 20161020 Granted publication date: 20110914 Pledgee: The development of small and medium-sized enterprises financing Company Limited by Guarantee Jieshou City Pledgor: Anhui Huaxin Natural Medicine Co., Ltd. Registration number: 2016990000886 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171211 Granted publication date: 20110914 Pledgee: The development of small and medium-sized enterprises financing Company Limited by Guarantee Jieshou City Pledgor: Anhui Huaxin Natural Medicine Co., Ltd. Registration number: 2016990000886 |